Member Info for Parpaing

The start of the roadshow?

Love it !☺

I believe that the SP is going to plan or it will be a huge embarrassment to Scott, the multinational BOD and the high profile companies that believe in their investments. I'm still in and have the patience for upside.

"The acquisition of 3D seismic is planned for the first half of 2016. The new seismic data will allow better resolution of shallow plays as well as imaging of deeper sections. Tower expects to be drilling in 2017/18." Ha ha ha. Asher couldn't find oil in a fish & chip shop.

Seismic studies have proved to be a waste of time. Just save the survey money and drill a few holes - today, not next year. Get a diver down , look for the oil seeps and drill a seep. Its as simple as that.

This is money TRP needs for more seismic studies looking for the 'glowing in the dark' black stuff. I've managed to turn 5k into a sum that wouldn't buy me lunch. Asher has more chance of placing a half a pound of butter into a tiger's ear with a red hot needle than get me to buy another share in this scam.

Hello Mr.Leeson ! Good to hear from you. Thanks for the press release. All good news and just right for the run-up to a listing in September. Then wait until the SP reaches 25 bucks and I'm out at even Stevens. When the SP gets to 50 USD I might just break even on all the other AIM disasters - BPC, TRP, BIOM and RBS.

Steady lads, standfast together now.

You have hit the nail on the head with your choice of words in your message "better bets". That's exactly how to describe stock exchanges nowadays - smoke-filled betting shops. Not so long ago, one had a stockbroker where 'trust' was the watch word. You could invest in a company, receive paper share certificates to treasure and hopefully the company was well managed and dividends would filter in every so often. Now, unscrupulous people form a company simply to derive a salary from the savings of investors. Even the banks are charging to 'hold' my shares.The advent of computers and super fast trading has removed the human element and inspire greed beyond belief. The markets should realise that you can fool some of the people some of the time but you can't fool all of the people all of the time. Hence the collapse of our current banking system and of course, the stock markets. The currency markets are the most blatantly manipulated scenarios I have ever seen. The money marketeers have managed to turn themselves into a similar system of the antique trade, where a handful of the 'respected' decide what is going to be hot and when. We haven't got a chance unless you happen to have a super-fast Internet connection, a beefed up computer running six screens and your own bespoke algorithm. My portfolio of companies like RBS that are totally devoid of moral compasses have all turned into an embarrassing waste of hard-earned family money. I'm just waiting for the 'I-told-you-so' brigade to turn up and gloat.

Snoots - Yes, you are right. I forgot July 4th. According to my broker, the shares would have to be 27 USD each just to get my money back. Unless of course, Scott is going to award the long-suffering shareholders some free divi shares to make us happy. No doubt the IPO will have some super news to back it up.

If I can find this info, then the BOD and Scott must have known that they would have to list on the OTC for at least a year - which they didn't tell us. The reverse merger might have been cheaper, but the listing will take longer because of the reasons I gave you all earlier. A 50 per c3ent reduction in salaries during this period would have kept more money in the pot. I'm assuming that the SEC approval will happen in late August early September, followed by the IPO and then an eventual exit by the BOD due to a takeover / merger or similar.

LordSnooty, This is where I got the info from: (c) Reverse Mergers (1) A Company that is formed by a Reverse Merger (a "Reverse Merger Company") shall be eligible to submit an application for initial listing only if the combined entity has, immediately preceding the filing of the initial listing application: (A) traded for at least one year in the U.S. over-the-counter market, on another national securities exchange, or on a regulated foreign exchange, following the filing with the Commission or Other Regulatory Authority of all required information about the transaction, including audited financial statements for the combined entity; and (B) maintained a closing price of $4 per share or higher for a sustained period of time, but in no event for less than 30 of the most recent 60 trading days. (2) In addition to satisfying all of Nasdaq's other initial listing requirements, a Reverse Merger Company will only be approved for listing if, at the time of approval, it has: (A) timely filed all required periodic financial reports with the Commission or Other Regulatory Authority (Forms 10-Q, 10-K or 20-F) for the prior year, including at least one annual report. The annual report must contain audited financial statements for a full fiscal year commencing after filing the information described in paragraph (1)(A) above; and (B) maintained a closing price of $4 per share or higher for a sustained period of time, but in no event for less than 30 of the most recent 60 trading days prior to approval. (Source: http://nasdaq.cchwallstreet.com/NASDAQTools/PlatformViewer.asp?selectednode=chp%5F1%5F1%5F4%5F2&manual=%2Fnasdaq%2Fmain%2Fnasdaq%2Dequityrules%2F )

In recent years, reverse mergers have been subject to increasing abuse. In late 2011, the SEC moved to increase shareholder protections by prohibiting reverse merger firms from applying to list on the NASDAQ, the New York Stock Exchange, and NYSE Amex until they had completed a I-year "seasoning period" by trading on the OTC Bulletin Board or on another regulated US or foreign exchange. The firm also must file all required reports with e SEC and maintain a minimum share price for at least 30 of the 60 trading days before its listing application can be submitted to an exchange and the exchange can approve the listing. During this seasoning period, the shares of such firms taken public through a reverse merger tend to be highly illiquid, selling at significant discounts from the prices when issued. (source: Mergers, acquisitions and other Restructuring activities, by Donald DePamphilis).

The reverse stock split is intended to fulfill the stock price requirements for listing on NASDAQ since the requirements include that the Company’s common stock must maintain a minimum closing price for 30 of 60 trading days. This 60 period ends on the 23rd August. As the SP has maintained the 30 day minimum, the SEC approval should be at the end of August or beginning of September. Then the IPO roadshow can take place. That's how long this piece of string is.

Has anyone got any proof that drilling on behalf of TRP actually happened?

Don't worry Aymesco1, it's "glowing in the dark". All the BOD has to do is find it. Unfortunately, the BOD couldn't find oil in a Fish & Chip shop.

check out the new xbiod website http://www.xeneticbio.com/

The MMs are using the brexit as an excuse to make their free summer holiday money as usual. Just before the city goes on holiday, the GBP to EUR will climb and the bankers buy Euros with the money they made on companies like RBS. I have seen RBS shares at 10p a few years ago, so the SP hasn't hit bottom yet. Don't forget the MMs can drive any share down to near zero and then back up again really fast. The MMs hold the boo kand only they know where punters have put their money.

The reverse stock split is intended to fulfill the stock price requirements for listing on NASDAQ since the requirements include that the Company’s common stock must maintain a minimum closing price for 30 of 60 trading days. so we will have to wait until August / September for SEC approval. This will coincide with France's decision to remove the sanctions applied to Russia. The UN is pushing for Ukraine and Russia to kiss and make up by August.

Specialist biopharmaceutical company Shire (LSE: SHP) enjoyed a storming run but it has stumbled lately, its share price falling 20% over the past 12 months. The revival may have already begun, helped by a 17% rise in first-quarter revenues to £1.7bn. Sales, earnings and EPS growth all posted double-digit growth, as did sales of leading treatments Vyvanse, Lialda/Mezavant and Cinryze. While short-term performance is strong, the longer-term worry is that it faces a steep patent cliff in four or five years time. It therefore needs to invest heavily in replenishing its drug pipeline, hence the £22bn takeover of Illinois-based Baxalta. This will bring treatments for rare blood conditions, cancers and immune system disorders, as well as generating $500m of cost savings over three years, a target many analysts reckon is over-optimistic. https://uk.finance.yahoo.com/news/aviva-plc-15-prudential-plc-074032921.html We've got over 200 patents. any thoughts ?